BRCA1 and neoplasm: We, thus, evaluated the percentage of RAD51 foci/geminin-positive (RAD51+/GMN+) cells and BRCA1 foci/geminin-positive (BRCA1+/GMN+) cells in the FFPE tumor samples of the same patients (Figure 2).